Dr. Faught is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12 Executive Park Dr NE
Atlanta, GA 30329Phone+1 404-778-3444
Summary
- I am a neurologist specializing in EEG and epilepsy. I direct the Emory Epilepsy Center.
My research interests are antiepileptic drugs and pharmacoepidemiology.
Clinical Expertise
- Electroencephalography, Epilepsy, Clinical neurophysiology
Education & Training
- University of Virginia Medical CenterFellowship, Clinical Neurophysiology, 1979 - 1980
- University of Virginia Medical CenterResidency, Neurology, 1977 - 1978
- University of Virginia Medical CenterResidency, Neurology, 1975 - 1977
- University of Virginia Medical CenterInternship, Internal Medicine, 1972 - 1973
- Vanderbilt University School of MedicineClass of 1972
- Harvard UniversityAB, Social Relations, Cum Laude, 1964 - 1968
Certifications & Licensure
- GA State Medical License 2009 - 2025
- AL State Medical License 1980 - 2010
- American Board of Psychiatry and Neurology Neurology
- American Board of Clinical NeurophysiologyEEG
Awards, Honors, & Recognition
- Platinum Provider Award Emory Healthcare, 2019
- Hans Berger Lecturer Award Medical College of Virginia, 2005
- Fellow American Neurological Association, 2012
- Join now to see all
Publications & Presentations
PubMed
- 69 citationsDetection of generalized tonic-clonic seizures using surface electromyographic monitoringJonathan J. Halford, Michael R. Sperling, Dileep Nair, Dennis J. Dlugos, William O. Tatum
Epilepsia. 2017-11-01 - 28 citationsBGG492 (selurampanel), an AMPA/kainate receptor antagonist drug for epilepsy.Edward Faught
Expert Opinion on Investigational Drugs. 2014-01-01 - 820 citationsA Comparison of Four Treatments for Generalized Convulsive Status EpilepticusDavid M. Treiman, P. D. Meyers, N. Y. Walton, Joseph F. Collins, C Colling
The New England Journal of Medicine. 1998-09-17
Journal Articles
- Recurrent mutations in DNAJC5 cause autosomal dominant Kufs diseaseCadieux-Dion M, Andermann E, Lachance-Touchette P, Ansorge O, Meloche C, Barnabe’ A, Kuzniecky RI, Andermann F, Faught E, Leonberg S, Damiano JA, Berkovic SF, Rouleau..., Clinical Genetics, 1/1/2013
- Tiagabine in clinical practice Effects on seizure control and behaviorVossler DG, Morris GL, Harden CL, Montouris G, Faught E, Kanner AM, Fix A, French JA, Epilepsy and Behavior, 1/1/2013
- Trigeminal stimulation: a superhighway to the brain? (editorial)Faught E, Tatum WO, Neurology, 1/1/2013
- Join now to see all
Press Mentions
- Drug Tolerability, Dosing Frequency Impacts Adherence in EpilepsyJuly 6th, 2016
Committees
- Chair, ILAE Task Force on Epilepsy in the Elderly 2017 - 2020
Professional Memberships
- Fellow
- Fellow
- American Neurological AssociationMember
- Southern Epilepsy and EEG SocietyMember
- American Clinical Neurophysiology SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: